SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-162574
Filing Date
2017-05-08
Accepted
2017-05-08 16:06:56
Documents
3
Period of Report
2017-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d392684d8k.htm 8-K 16702
2 EX-99.1 d392684dex991.htm EX-99.1 37700
3 GRAPHIC g392684ex991pg01.jpg GRAPHIC 17908
  Complete submission text file 0001193125-17-162574.txt   80319
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 17822243
SIC: 2834 Pharmaceutical Preparations